Skip to content
Home/Companies/Pharma/tranScrip
TR

tranScrip

Pharma·UK·Active·5yr hold

tranScrip is a healthcare company, headquartered in UK.

Entry
2021
Hold
5yr
Status
Active
Est. EV
–

Who owns tranScrip?

tranScrip is currently owned by Palatine Private Equity through Palatine Impact Fund II (2023 vintage), since 2021.

Hand-verified · updated 2026-04-21

Palatine Private Equity
Investor
Palatine Private Equity
Palatine Impact Fund II · 2023 · Impact

Key facts

HQUK
SectorHealthcare

More from Palatine Impact Fund II

Other portfolio companies in the same fund.

Isle Utilities
Active
Business ServicesUK· 2024
The MOLE Clinic
Active
HealthcareUK· 2024
Papilo
Active
Business ServicesUK· 2023
Cura Terrae
Active
Business ServicesUK· 2022
Inclusive Employers
Active
Business ServicesUK· 2022

More PE-backed in Pharma

Comparable pharma deals from other GPs.

Delpharm
Active
SocadifFrance
Laboratoires Delbert
Active
SocadifFrance
IRAB
Active
ARCHIMEDSpain· 2026
Biogaran
Active
BC PartnersFrance· 2025
Dec Group
Active
capitonSwitzerland· 2025
Essential Pharma
Active
Penta CapitalUK· 2025
Data refreshed weekly · Sourced from public filings